Moreover, HDAC4 overexpression restored the impacts of Rh4 on the malignant phenotypes of HCC cells, suggesting that Rh4 inhibited the development of HCC by inactivating the HDAC4/IL-6/STAT3 signaling. The gene discussed is IL6; the disease is hepatocellular carcinoma.